YOUR PARTNER FOR YOUR PRECLINICAL DEVELOPMENT
compliant, specialized in pharmaceutical development of new active molecules.
WELCOME TO C.RIS PHARMA!
C.RIS Pharma is a Contract Research Organization (CRO) specialized in non-clinical safety studies for product registration in accordance with current International regulatory requirements.
C.RIS Pharma is a leading CRO in Europe with over 18 years of Worldwide experience, providing high quality non-clinical research management to National and International pharmaceutical companies and other health-related organizations.
Proficiency, Experience, Ethics and Punctuality for
non-clinical safety product development
Scientific expertise for your research
C.RIS Pharma offers a full range of experimental and consultancy services, performed by skilled professionals, for the development and safety assessment of:
Pharmaceutical industries
Our scientific and regulatory expertise in the Health and Safety field enables us to offer our support for the development of your active principles – from small molecules to cell therapies and medical devices – and ensure their efficiency (oncology, metabolic diseases, infectious diseases, bone diseases,…) as well as their safety (in vitro and in vivo toxicology).
Agrofood industries
C.RIS Pharma is also here to assist you in your food product development by supplying efficacy models (for food supplements for example) and conducting your toxicology programs. We are constantly expanding our Novel Food expertise.
Cosmetic industries
C.RIS Pharma offers to test the toxicity and the efficiency of your compounds on different experimental models.
Extensive scientific and technological expertise
Combined with skills in project management and communication, together with the ability of providing clients with competitive, fast and reliable service, extensive scientific and technological expertise, these qualities make C.RIS Pharma the partner of choice for your product development.
C.RIS Pharma’s projects are conducted according to the Good Laboratory Practices (GLP) compliance by the French National Agency for Medicines and Health Products Safety (ANSM) and accredited for the “Crédit Impôt Recherche” by the French Ministry of Research.
